Terry Faleye, MPAS, PA-C

Lakshi Aldredge, MSN, ANP-BC, comments on the implications of long-term safety data in patients who may not have responded to initial treatment of plaque psoriasis.

Laura Bush, DMSc, PA-C, provides an overview of systemic treatment options for patients with plaque psoriasis, highlighting the follow-up process once treatment has been implemented.

Jennifer Conner, MPAS, PA-C, and Lakshi Aldredge, MSN, ANP-BC, comment on approaches to escalating treatment of plaque psoriasis from topical therapy to systemic therapy and initiating that conversation with the patient.

Experts in dermatology review a case of a patient with plaque psoriasis concentrated on her hands and discuss taking the patient’s preferences into consideration when selecting treatment.

Laura Bush, DMSc, PA-C, and Terry Faleye, MPAS, PA-C, discuss metrics to determine clearance in plaque psoriasis and how the provider’s expectations may be different from the patient’s expectations.

Lakshi Aldredge, MSN, ANP-BC, discusses how speed of treatment response guides treatment selection for the patient, taking patient preference into consideration. Jennifer Conner, MPAS, PA-C, comments on treatment failure in plaque psoriasis.

Jennifer Conner, MPAS, PA-C, Terry Faleye, MPAS, PA-C, and Laura Bush, DMSc, PA-C, comment on approaches to treatment selection in managing plaque psoriasis, highlighting topical treatment in combination with other therapies.

Lakshi Aldredge, MSN, ANP-BC, reviews the mechanism of action of deucravacitinib, commenting on its efficacy in the treatment of plaque psoriasis.

Experts discuss how the understanding of plaque psoriasis has changed over the years and, with that, how the treatment landscape has expanded.

Alexa Hetzel, MS, PA-C, leads a discussion on the role both physician assistants and nurse practitioners play in diagnosis and management of plaque psoriasis, commenting on the dermatology environment vs the primary care environment.